March 5, 2026: FDA Issues Warning Letter to Novo Nordisk About Reporting Adverse Events for its GLP-1s The FDAs Center for Drug Evaluation and Research (CDER) has issued a warning letter to Novo Nordisk, Ozempics maker
Provider-reviewed GLP-1 and peptide therapy, delivered to your door
Bacteriostatic water, syringes, alcohol prep pads, and cold-chain shipping add $56$93 per month
Klebanoff believes the cost of the drugs will ultimately decrease as the market becomes more competitive
In controlled studies, rats subjected to laparotomy and intestinal manipulation showed delayed gastric emptying with 78%5% of a meal remaining in the stomach after 15 minutes in vehicle-treated controls
See also Tani Y, Tokuda M, Nishimoto N, Yokoi H, Izumori K